Trade Bioventus Inc. - BVS CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.09 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001124% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 7.68 |
| Open | 7.63 |
| 1-Year Change | 83.41% |
| Day's Range | 7.49 - 7.66 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 25, 2025 | 7.60 | 0.00 | 0.00% | 7.60 | 7.67 | 7.45 |
| Apr 24, 2025 | 7.68 | 0.10 | 1.32% | 7.58 | 7.85 | 7.49 |
| Apr 23, 2025 | 7.54 | -0.03 | -0.40% | 7.57 | 7.82 | 7.54 |
| Apr 22, 2025 | 7.44 | -0.09 | -1.20% | 7.53 | 7.68 | 7.37 |
| Apr 21, 2025 | 7.46 | 0.03 | 0.40% | 7.43 | 7.73 | 7.30 |
| Apr 17, 2025 | 7.77 | 0.34 | 4.58% | 7.43 | 7.80 | 7.43 |
| Apr 16, 2025 | 7.73 | 0.39 | 5.31% | 7.34 | 7.88 | 7.34 |
| Apr 15, 2025 | 7.70 | -0.07 | -0.90% | 7.77 | 8.09 | 7.58 |
| Apr 14, 2025 | 7.87 | 0.27 | 3.55% | 7.60 | 7.95 | 7.54 |
| Apr 11, 2025 | 7.43 | 0.16 | 2.20% | 7.27 | 7.52 | 7.10 |
| Apr 10, 2025 | 7.54 | -0.33 | -4.19% | 7.87 | 7.87 | 7.33 |
| Apr 9, 2025 | 7.90 | 0.49 | 6.61% | 7.41 | 8.29 | 7.22 |
| Apr 8, 2025 | 7.61 | -0.72 | -8.64% | 8.33 | 8.39 | 7.51 |
| Apr 7, 2025 | 8.22 | 0.55 | 7.17% | 7.67 | 8.50 | 7.50 |
| Apr 4, 2025 | 8.28 | -0.45 | -5.15% | 8.73 | 8.73 | 8.12 |
| Apr 3, 2025 | 9.11 | 0.09 | 1.00% | 9.02 | 9.11 | 8.76 |
| Apr 2, 2025 | 9.46 | 0.37 | 4.07% | 9.09 | 9.52 | 9.09 |
| Apr 1, 2025 | 9.33 | 0.46 | 5.19% | 8.87 | 9.34 | 8.87 |
| Mar 31, 2025 | 9.10 | 0.21 | 2.36% | 8.89 | 9.18 | 8.77 |
| Mar 28, 2025 | 8.97 | -0.10 | -1.10% | 9.07 | 9.10 | 8.74 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Bioventus Inc. Company profile
About Bioventus Inc
Bioventus Inc is a global medical device company. The Company is focused on developing and commercializing clinically and minimally invasive treatments that engage and enhance the body’s natural healing process. The Company’s portfolio of products includes OA joint pain treatment and joint preservation, bone graft substitutes and minimally invasive fracture treatment. The OA joint pain treatment and joint preservation is focused on orthopedics. Its bone graft substitutes (BGSs) offers portfolio of products including human tissue allografts and synthetics. Its BGS products can be used in conjunction with any orthopedic fixation and spinal fusion implant. They are designed to improve bone fusion rates following spinal fusion and other orthopedic surgeries and reduce the need for using the patient’s own bone.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Bioventus Inc revenues increased 34% to $430.9M. Net income applicable to common stockholders increased from $4.4M to $19.4M. Revenues reflect U.S. segment increase of 32% to $387.6M, International segment increase of 58% to $43.3M. Net income benefited from Stock-based Compensation in SGA decrease from $10.1M (expense) to $4.5M (income), Foreign Exchange Gain/Loss increase of 13% to $132K (income).
| Industry: | Medical Equipment |
4721 Emperor Boulevard, Suite 100
DURHAM
NORTH CAROLINA 27703
US
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com